Back to Hematology
Hematologyv2006Evidence-Based

HEMORR₂HAGES Score for Major Bleeding Risk

Quantifies hemorrhage risk in elderly patients with atrial fibrillation on anticoagulation therapy. The score helps clinicians assess bleeding risk when considering anticoagulation for stroke prevention in AF patients.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
hemorr2hages score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The HEMORR₂HAGES Score for Major Bleeding Risk is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within hematology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

HEMORR₂HAGES Score = H (1) + E (1) + M (1) + O (1) + R (1) + R (2) + H (1) + A (1) + G (1) + E (1) + S (1)

Clinical Pearls & Practice Notes

  • HEMORR₂HAGES is an acronym where each letter represents a risk factor
  • The second 'R' (Rebleeding) is worth 2 points, all other factors are worth 1 point
  • Designed specifically for elderly patients (>75 years) with atrial fibrillation
  • Should be used in conjunction with stroke risk assessment tools like CHA₂DS₂-VASc
  • Genetic factors (CYP 2C9 polymorphisms) may not be routinely available in clinical practice

Evidence & Literature Citations

  1. Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J. 2006 Mar;151(3):713-9.
  2. Apostolakis S, Lane DA, Guo Y, Buller H, Lip GY. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study. J Am Coll Cardiol. 2012 Aug 28;60(9):861-7.

Score Interpretation Ranges

Low Risk0 – 1 pts

Score 0-1

Intermediate Risk2 – 3 pts

Score 2-3

High Risk4 – 12 pts

Score ≥4

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.